Delivery Order SPE2DB25D2207-SPE2DB25FQRMZ
- Not listed
- The Defense Logistics Agency awarded a $14,582.36 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,812.16 and an ultimate completion date of April 22, 2025. The contract was competitively awarded with no set-aside designation. Descovy is an antiretroviral medication used in HIV treatment and prevention, reflecting the critical pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $4,739.71 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania to the same location. Descovy is an antiretroviral medication used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 tablets, with a ceiling value of $2,915.55. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,842.20 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $23,354.50 and an ultimate completion date of September 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 tablets, with a ceiling value of $10,790.10 and an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $13,063.67 with firm fixed pricing, represents a pharmaceutical procurement under the agency's medical supply chain operations. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and...
- The Defense Logistics Agency awarded a $8,390.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 units of Descovy 200-25 mg tablets. The award, issued on April 28, 2025, with an ultimate completion date of April 29, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. Descovy is an antiretroviral medication used in HIV treatment and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $27,254.12, represents a non-competitive set-aside award with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRMZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This order, valued at $7,045.86 under a firm fixed-price contract type, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be fulfilled at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. Descovy is an antiretroviral medication used in HIV prevention and treatment, reflecting the Department of Defense's ongoing pharmaceutical supply requirements for military personnel and beneficiaries. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery/Indefinite Quantity vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's significant IDC with DLA reflects its capability to support military healthcare programs globally and aligns with the Defense Logistics Agency's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 8/14/25 |